Itron Inc (ITRI) valuation
Itron P/E ratio history
Itron trades at 15.5 times its earnings over the last twelve months and 13.9 times the earnings analysts expect over the next twelve. At its last 6 fiscal year ends its P/E ranged from 14.3 (year to Dec 2025) to 76.7 (year to Dec 2016), with a median of 41.3.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Dec 31, 2025 | $92.86 | $6.50 | 14.3 | 15.0 |
| Dec 31, 2024 | $108.58 | $5.18 | 21.0 | 21.5 |
| Dec 31, 2023 | $75.51 | $2.11 | 35.8 | 24.8 |
| Dec 31, 2022 | $50.65 | -$0.22 | n/m | — |
| Dec 31, 2021 | $68.52 | -$1.83 | n/m | 33.8 |
| Dec 31, 2020 | $95.90 | -$1.44 | n/m | — |
| Dec 31, 2019 | $83.95 | $1.22 | 68.8 | — |
| Dec 31, 2018 | $47.29 | -$2.57 | n/m | — |
| Dec 31, 2017 | $68.20 | $1.46 | 46.7 | — |
| Dec 31, 2016 | $62.85 | $0.82 | 76.7 | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Itron valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| ItronITRI | $4.20B | 15.5 | 13.9 | 1.8 |
| Q2QTWO | $4.18B | 39.5 | 20.6 | 4.8 |
| Core ScientificCORZ | $4.21B | — | — | 9.6 |
| BeldenBDC | $4.13B | 23.8 | 10.9 | 1.3 |
| Badger MeterBMI | $4.30B | 34.3 | 30.5 | 4.9 |
| FreshworksFRSH | $4.07B | 23.4 | 19.7 | 4.5 |
| D-Wave QuantumQBTS | $3.94B | — | — | 317.1 |
| Kulicke And Soffa IndustriesKLIC | $3.88B | 33.8 | 13.7 | 4.1 |
| SezzleSEZL | $4.54B | 29.4 | 21.4 | 8.5 |
| Peer median | 31.6 | 20.1 | 4.8 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: ITRI financials · ITRI returns
No forecast, no recommendation. This page describes Itron Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.